Chondrocyte-mediated catabolism of aggrecan: aggrecanase-dependent cleavage induced by interleukin-1 or retinoic acid can be inhibited by glucosamine.

@article{Sandy1998ChondrocytemediatedCO,
  title={Chondrocyte-mediated catabolism of aggrecan: aggrecanase-dependent cleavage induced by interleukin-1 or retinoic acid can be inhibited by glucosamine.},
  author={J. Sandy and D. Gamett and V. Thompson and C. Verscharen},
  journal={The Biochemical journal},
  year={1998},
  volume={335 ( Pt 1)},
  pages={
          59-66
        }
}
  • J. Sandy, D. Gamett, +1 author C. Verscharen
  • Published 1998
  • Chemistry, Medicine
  • The Biochemical journal
  • A rat chondrosarcoma cell line and bovine cartilage explants have been used to study the control of aggrecan degradation by chondrocytes treated with interleukin-1 (IL-1) or retinoic acid (RA). Aggrecan fragment analysis with anti-neo-epitope antibodies suggests that aggrecanase (an as yet unidentified enzyme) is the only aggrecan-degrading proteinase active in these cultures. With rat cells, aggrecanase converts the aggrecan core protein into two major G1-domain-bearing products (60 kDa with a… CONTINUE READING
    152 Citations

    Figures and Topics from this paper

    10mM glucosamine prevents activation of proADAMTS5 (aggrecanase-2) in transfected cells by interference with post-translational modification of furin.
    • 10
    • Highly Influenced
    Expression and Regulation of Aggrecanase in Arthritis: The Role of TGF-β1
    • 141
    • PDF
    Aggrecanase-mediated cartilage degradation.
    • E. Arner
    • Chemistry, Medicine
    • Current opinion in pharmacology
    • 2002
    • 162